Latest Carefusion Corp (CFN) Headlines
Upcoming Conferences, Financial Results, New Products, and Awareness Campaigns - Analyst Notes on Align Technology, LabCorp, Insulet, CareFusion, and DexCom
PR Newswire - Tue Mar 11, 8:20AM CDT
Today, Analysts Review released its analysts' notes regarding Align Technology, Inc. (NASDAQ:ALGN), Laboratory Corp. of America Holdings (NYSE:LH), Insulet Corporation (NASDAQ
ODD), CareFusion Corporation (NYSE:CFN), and DexCom, Inc. (NASDAQ
XCM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Insider Trading Alert - CFN, ANF And VRSN Traded By Insiders
at The Street - Wed Mar 05, 12:30PM CST
Stocks with insider trader activity include CFN, ANF and VRSN
In 2013, the European Market for Female Neonatal Diagnostic Devices was Valued at Over 410 Million
M2 - Fri Feb 28, 10:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/dj9zpl/european_markets) has announced the addition of the "European Markets for Female and Neonatal Diagnostic Devices" report to their offering. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, infant warmers and incubators. Europe's economic climate will continue to influence the many different sectors examined in this report. Capital equipment sales will be negatively influenced by health care restraints due to economic instability; this effect will be particularly pronounced in the more pricesensitive Southern European countries. The well- established and mature OB/GYN ultrasound segment will continue to dominate this market throughout the forecast period. This will be followed by the breast imaging segment, representing just over a quarter of the overall market. This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Main Segments Included - European Female and Neonatal Diagnostic Device Market - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics and Gynecology Ultrasound Market - Infant Warmer and Incubator Market Companies Mentioned - Agfa - Anthem - Ardo Medical AG - Argon Medical - Atom Medical International - B. Braun - BK Medical - Biosound Esaote - Brestige - C .R. Bard - CareFusion - Carestream - Cobams - Cooper Surgical - DMS Group - Demetech - Devicor - Draeger Medical - Echosens - Ethicon Endo-Surgery - Fisher & Paykel - Fujifilm - Fujifilm-SonoSite - Fukuda Denshi - GE Healthcare - Ginevri - Heinen-Lowenstein - Hitachi Medical Systems - Hitachi-Aloka - Hologic - IMS Giotto - International Biomedical - Invivo Interventional Instruments - Johnson & Johnson - Konica Minolta - Machnet - Mammotome - Medical ECONET - Mermaid Medical - Metaltronica - Mindray - Mediprema - NORAS - Natus Medical - Osteometer Meditech - Philips Healthcare - Planmed - Planmed OY - Samsung Medison - Siemens Healthcare - Sunlight Medical - Supersonic Imagine - Toshiba - Ultrasonix - Weyer - Zonare Medical Systems For more information visit http://www.researchandmarkets.com/research/dj...an_markets About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Even With Growth Opportunities Ahead, Is Hospira Overvalued?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Thu Feb 27, 1:30PM CST
Leading specialty injectables and infusion pump manufacturer Hospira has suffered greatly from largely self-inflicted wounds over the past couple of years. A lackadaisical approach to proper plant management has led to numerous FDA warning letters...
Concise Analysis of the International Portable Oxygen Concentrators - Forecasts to 2018
M2 - Wed Feb 26, 6:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/3rf662/portable_oxygen) has announced the addition of a new report "Concise Analysis of the International Portable Oxygen Concentrators - Forecasts to 2018" to their offering. Worldwide markets are poised to achieve continuing growth as the aging population worldwide needs homecare oxygen treatment. Older people develop COPD and other respiratory conditions where oxygen is able to improve the quality of the life in a dramatic manner. Portable devices have become affordable and support a mobile lifestyle even while on oxygen. There has been a quantum improvement in the portable oxygen concentrator technology. Less weight, more power are the characteristics of the new portable units that begin to rival the larger home units. The huge jump in technology is illustrated by the effectiveness of the Inogen G3 and the about to be released VBox Trooper. Innovation started with Inogen One G3 and AirSep's LifeStyle are the less-than-10-pound battery-operated concentrator. AirSep has re-engineered the unit down to a 2 pound device. Newer portable oxygen concentrators can be used as multipurpose devices. Portable oxygen concentrator technology has been instantiated many times over, but in a most compelling manner by Inogen as the Inogen oxygen concentrator which represents a technological breakthrough. The Inogen One G3 is a complete departure from current mainstream technologies. It represents a shift away from standard large, bulky, stationary concentrator systems and inefficient, heavy, and impractical portable devices. Key Topics Covered: 1. Portable Oxygen Concentrator Market Description and Market Dynamics 2. Portable Oxygen Concentrator Market Shares and Forecasts 3. Portable Oxygen Concentrator Product Description 4. Oxygen Concentrator Technology 5. Respiratory Equipment Company Description Companies Mentioned : - Air Liquide - Braun and Company - CareFusion / Intermed Equipment - Chart Industries - Covidien - DeVilbiss Healthcare - Drive Medical - Dr?ger - Fanem - Fisher & Paykel Healthcare - GE Healthcare - Gardner Denver / Thomas Compressors - Getinge Group AB / Maquet - Graham Field - Hamilton Medical - Heinen & Loewenstein GmbH & Co - Inogen - Inova Labs - Invacare - Jiuxin Medical - Leistung Engineering - Longfian Scitech - Merits - Nidek Medical - O2 Concepts - OSI Systems - Philips Healthcare - ResMed Sleep Disordered Breathing (SDB) - Smiths Group plc / Smiths Medical - Teijin - Teleflex Incorporated / Teleflex Medical - Terumo - UltraNebs - VBox Trooper - Vitality Medical - Vygon For more information visit http://www.researchandmarkets.com/research/3r...ble_oxygen
Minimally Invasive Vertebral Compression Fracture Repair Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Mon Feb 24, 5:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/8m57sq/minimally) has announced the addition of the "Minimally Invasive Vertebral Compression Fracture Repair Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Collapse of the vertebrae due to trauma, osteoporosis or other causes of weakening of the vertebrae is known as vertebral compression fracture (VCF). VCF is more common in people with low bone mass or suffering from osteoporosis. Some of the common symptoms of VCF include, back pain lasting for more than 2-3 weeks, limited spinal mobility, vertebral height loss over time and kyphosis, disability and deformity over a period of time. Vertebral compression fracture is treated primarily with pharmacological therapy and prolonged bed rest. Surgically, VCFs are treated with minimally invasive VCF repair techniques in cases where medicinal therapies fail to cure VCF. Minimally invasive vertebral compression repair techniques include two procedures, namely, vertebroplasty and balloon kyphoplasty. Both vertebroplasty and kyphoplasty involve injection of medical grade cement in the fractured vertebra. Kyphoplasty is a newer and evolved form of vertebroplasty, where a balloon is inserted in the vertebral body and inflated to restore the original height of the collapsed vertebra and is thereafter followed by cement injection. Vertebroplasty successfully relives pain and enhances mobility of the patient; while on the other hand, balloon kyphoplasty not only relives the pain but also restores vertebral height and assists in curing kyphosis. Kyphoplasty has also demonstrated a lesser complication rate post procedure when compared with vertebroplasty. This has over the time resulted in higher adoption of kyphoplasty procedures worldwide, particularly in North America. One of the major factors that is contributing to rapid increase in the adoption of kyphoplasty procedure in North America is the recommendation of the use of this technique by the American Academy of Orthopedic Surgeons (AAOS) for VCF repair when conventional drug administration fails to deliver the desired results. Considering the advantages of kyphoplasty over vertebroplasty, the kyphoplasty market share will rapidly increase in the near future. The global market for balloon kyphoplasty was worth USD 555.4 million in 2011. Key Topics Covered - Introduction - Executive Summary - Market Overview - Global Minimally Invasive Vertebral Compression Fracture Repair Market, by Technology - Global Minimally Invasive Vertebral Compression Fracture Repair Market, by Geography - Recommendations - Company Profiles Companies Mentioned - Alphatec Spine - CareFusion - Cook Medical - DFine - DePuy Synthes - Globus Medical - Medtronic - Parallax Medical - Stryker Corporation - Zimmer Holdings Incorporated For more information visit http://www.researchandmarkets.com/research/8m57sq/minimally About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
MedMined® Surveillance Advisor Named KLAS Category Leader For Infection Control And Monitoring
PR Newswire - Wed Feb 19, 7:30AM CST
CareFusion (NYSE:CFN), a leading global medical technology company, today announced its MedMined® Surveillance Advisor was named the Category Leader for Infection Control and Monitoring by KLAS, an organization that independently monitors health care information technology performance through the active participation of thousands of health care organizations.
Children's Hospitals and Clinics of Minnesota Receives 2014 Intelligent Hospital Award
PR Newswire - Tue Feb 18, 7:30AM CST
The RFID in Healthcare Consortium (RHCC) and IntelligentHospital.org today announced that Children's Hospitals and Clinics of Minnesota has received a 2014 Intelligent Hospital Award for "Improving the Patient Experience: Care and Safety" for its infusion pump interoperability solution collaboration with CareFusion (NYSE: CFN) and Cerner (NASDAQ: CERN).
ICU Medical, Inc. Names Vivek Jain as New Chief Executive Officer and Chairman
GlobeNewswire - Wed Feb 12, 3:07PM CST
ICU Medical, Inc., (Nasdaq:ICUI), a leader in innovative medical devices used in infusion therapy, oncology and critical care applications, announced today the appointment of Vivek Jain as chairman and chief executive officer effective February 13, 2014, concluding a transition process that began when Dr. George Lopez announced his decision to retire as CEO in the fall of 2013. Steve Riggs, the Company's current acting Chief Executive Officer, will immediately resume his previous responsibilities as vice president of Operations.
BlueCross BlueShield of Tennessee Selects RxAnte To Provide Medication Quality Analytics
PR Newswire - Wed Feb 12, 7:00AM CST
Today, RxAnte, Inc., a health care analytics and technology company specializing in improving medication use, announced that BlueCross BlueShield of Tennessee, Inc. joins a growing list of health care organizations working with RxAnte to improve patient health. Under the terms of the agreement, RxAnte will provide two of its software solutions and analytic tools to BlueCross BlueShield of Tennessee to guide medication improvement programs for their Medicare Advantage population.
Insider Trading Alert - CFN, SCHW, BSX, HES And FCX Traded By Insiders
at The Street - Mon Feb 10, 9:15AM CST
Stocks with insider trader activity include CFN, SCHW, BSX, HES and FCX
Insider Trading Alert - CFN, MD, PNC, ITMN And PLCM Traded By Insiders
at The Street - Thu Feb 06, 11:00AM CST
Stocks with insider trader activity include CFN, MD, PNC, ITMN and PLCM
Watch for CareFusion to Potentially Rebound After Falling 2.91% Yesterday
Comtex SmarTrend(R) - Tue Feb 04, 4:33PM CST
CareFusion (NYSE:CFN) traded in a range yesterday that spanned from a low of $38.00 to a high of $39.47. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $39.48 on volume of 6.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
After Yesterday's Decline of 2.91%, CareFusion Offers Investors Better Value
Comtex SmarTrend(R) - Tue Feb 04, 4:32PM CST
CareFusion (NYSE:CFN) traded in a range yesterday that spanned from a low of $38.00 to a high of $39.47. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $39.48 on volume of 6.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CareFusion: Flat Earnings, Maintained View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 04, 1:58PM CST
Revenues in the quarter rose 1.4% (both in reported and constant currency) to $922 million, topping the Zacks Consensus Estimate of $912 million
CareFusion (CFN) Crosses Pivot Point Support at $39.21
Comtex SmarTrend(R) - Tue Feb 04, 9:07AM CST
Shares of CareFusion (NYSE:CFN) have bearishly opened below the pivot of $40.06 today and have reached the first support level of $39.21. Analysts will be watching for a cross of the next downside pivot targets of $38.63 and $37.19.
CareFusion Reports First Half Fiscal 2014 Results
PR Newswire - Mon Feb 03, 3:02PM CST
CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its second quarter of fiscal 2014, ended Dec. 31, 2013.
CareFusion Up on Terumo Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 31, 4:45PM CST
CareFusion announced an eight-year agreement with Terumo
Natus Medical Beats on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 30, 2:20PM CST
Natus Medical reported fourth-quarter 2013 adjusted earnings per share (EPS) of 37 cents, surpassing the Zacks Consensus Estimate of 32 cents. It also provided its revenue and EPS outlook for full year 2014.
Concise Analysis on the Internatiuonal Pharmacy Automation Market - Forecasts to 2016
M2 - Thu Jan 30, 5:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/hp6krz/global_pharmacy) has announced the addition of the "Concise Analysis on the Internatiuonal Pharmacy Automation Market - Forecasts to 2016" report to their offering. Increasing customer support services is one of the emerging trends in the Global Pharmacy Automation market. The vendors in the Global Pharmacy Automation market are providing all-inclusive customer support packages with the purchase or rental of pharmacy automation systems. Staff technicians are available toll-free 24 hours a day, 365 days a year for personalized technical support and operational guidance. Some of the vendors provide automated updates of the software and drug database which are included in the support package. Vendors are offering the end-users with several maintenance and post-purchase services to retain the customer base and to remain competitive in the market. The increase in technological innovations is one of the major drivers in the global pharmacy automation market. The demand for pharmacy automation products has increased significantly due to the technological advancements and sophisticated approaches in healthcare industry. Ongoing innovations are contributing to various healthcare operations on a regular basis. There has been increased emphasis on improving medication distribution by the companies and the pharmacies have become more receptive in accepting the same. The market is also expected to be driven by the introduction of advanced robotic prescription dispensing systems, central-fill systems, electronic-prescribing (e-prescribing), telehealth and automated kiosks during the forecast period. Further, the report discusses that intense competition among vendors is one of the major challenges in the Global Pharmacy Automation market. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Coverage 4. Market Landscape 5. Geographical Segmentation 6. Vendor Landscape 7. Buying Criteria 8. Market Growth Drivers 9. Drivers and their Impact 10. Market Challenges 11. Impact of Drivers and Challenges 12. Market Trends 13. Key Vendor Analysis 14. Other Reports in this Series Companies Mentioned: - CareFusion - Kirby Lester - McKesson - Omnicell - Parata Systems - ScriptPro - Swisslog Holdings For more information visit http://www.researchandmarkets.com/research/hp...l_pharmacy
Upcoming Conferences, Financial Results, New Products, and Awareness Campaigns - Analyst Notes on Align Technology, LabCorp, Insulet, CareFusion, and DexCom
PR Newswire - Tue Mar 11, 8:20AM CDT
Today, Analysts Review released its analysts' notes regarding Align Technology, Inc. (NASDAQ:ALGN), Laboratory Corp. of America Holdings (NYSE:LH), Insulet Corporation (NASDAQ
ODD), CareFusion Corporation (NYSE:CFN), and DexCom, Inc. (NASDAQ XCM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register Insider Trading Alert - CFN, ANF And VRSN Traded By Insiders
at The Street - Wed Mar 05, 12:30PM CST
Stocks with insider trader activity include CFN, ANF and VRSN
In 2013, the European Market for Female Neonatal Diagnostic Devices was Valued at Over 410 Million
M2 - Fri Feb 28, 10:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/dj9zpl/european_markets) has announced the addition of the "European Markets for Female and Neonatal Diagnostic Devices" report to their offering. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, infant warmers and incubators. Europe's economic climate will continue to influence the many different sectors examined in this report. Capital equipment sales will be negatively influenced by health care restraints due to economic instability; this effect will be particularly pronounced in the more pricesensitive Southern European countries. The well- established and mature OB/GYN ultrasound segment will continue to dominate this market throughout the forecast period. This will be followed by the breast imaging segment, representing just over a quarter of the overall market. This report covers Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland and the United Kingdom. This report pertains to a forecast period of 10 years (2010 - 2020) for the European market. Countries Included: Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K. Main Segments Included - European Female and Neonatal Diagnostic Device Market - Bone Densitometry Market - Breast Biopsy Device Market - Breast Imaging Market - Obstetrics and Gynecology Ultrasound Market - Infant Warmer and Incubator Market Companies Mentioned - Agfa - Anthem - Ardo Medical AG - Argon Medical - Atom Medical International - B. Braun - BK Medical - Biosound Esaote - Brestige - C .R. Bard - CareFusion - Carestream - Cobams - Cooper Surgical - DMS Group - Demetech - Devicor - Draeger Medical - Echosens - Ethicon Endo-Surgery - Fisher & Paykel - Fujifilm - Fujifilm-SonoSite - Fukuda Denshi - GE Healthcare - Ginevri - Heinen-Lowenstein - Hitachi Medical Systems - Hitachi-Aloka - Hologic - IMS Giotto - International Biomedical - Invivo Interventional Instruments - Johnson & Johnson - Konica Minolta - Machnet - Mammotome - Medical ECONET - Mermaid Medical - Metaltronica - Mindray - Mediprema - NORAS - Natus Medical - Osteometer Meditech - Philips Healthcare - Planmed - Planmed OY - Samsung Medison - Siemens Healthcare - Sunlight Medical - Supersonic Imagine - Toshiba - Ultrasonix - Weyer - Zonare Medical Systems For more information visit http://www.researchandmarkets.com/research/dj...an_markets About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Even With Growth Opportunities Ahead, Is Hospira Overvalued?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Thu Feb 27, 1:30PM CST
Leading specialty injectables and infusion pump manufacturer Hospira has suffered greatly from largely self-inflicted wounds over the past couple of years. A lackadaisical approach to proper plant management has led to numerous FDA warning letters...
Concise Analysis of the International Portable Oxygen Concentrators - Forecasts to 2018
M2 - Wed Feb 26, 6:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/3rf662/portable_oxygen) has announced the addition of a new report "Concise Analysis of the International Portable Oxygen Concentrators - Forecasts to 2018" to their offering. Worldwide markets are poised to achieve continuing growth as the aging population worldwide needs homecare oxygen treatment. Older people develop COPD and other respiratory conditions where oxygen is able to improve the quality of the life in a dramatic manner. Portable devices have become affordable and support a mobile lifestyle even while on oxygen. There has been a quantum improvement in the portable oxygen concentrator technology. Less weight, more power are the characteristics of the new portable units that begin to rival the larger home units. The huge jump in technology is illustrated by the effectiveness of the Inogen G3 and the about to be released VBox Trooper. Innovation started with Inogen One G3 and AirSep's LifeStyle are the less-than-10-pound battery-operated concentrator. AirSep has re-engineered the unit down to a 2 pound device. Newer portable oxygen concentrators can be used as multipurpose devices. Portable oxygen concentrator technology has been instantiated many times over, but in a most compelling manner by Inogen as the Inogen oxygen concentrator which represents a technological breakthrough. The Inogen One G3 is a complete departure from current mainstream technologies. It represents a shift away from standard large, bulky, stationary concentrator systems and inefficient, heavy, and impractical portable devices. Key Topics Covered: 1. Portable Oxygen Concentrator Market Description and Market Dynamics 2. Portable Oxygen Concentrator Market Shares and Forecasts 3. Portable Oxygen Concentrator Product Description 4. Oxygen Concentrator Technology 5. Respiratory Equipment Company Description Companies Mentioned : - Air Liquide - Braun and Company - CareFusion / Intermed Equipment - Chart Industries - Covidien - DeVilbiss Healthcare - Drive Medical - Dr?ger - Fanem - Fisher & Paykel Healthcare - GE Healthcare - Gardner Denver / Thomas Compressors - Getinge Group AB / Maquet - Graham Field - Hamilton Medical - Heinen & Loewenstein GmbH & Co - Inogen - Inova Labs - Invacare - Jiuxin Medical - Leistung Engineering - Longfian Scitech - Merits - Nidek Medical - O2 Concepts - OSI Systems - Philips Healthcare - ResMed Sleep Disordered Breathing (SDB) - Smiths Group plc / Smiths Medical - Teijin - Teleflex Incorporated / Teleflex Medical - Terumo - UltraNebs - VBox Trooper - Vitality Medical - Vygon For more information visit http://www.researchandmarkets.com/research/3r...ble_oxygen
Minimally Invasive Vertebral Compression Fracture Repair Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Mon Feb 24, 5:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/8m57sq/minimally) has announced the addition of the "Minimally Invasive Vertebral Compression Fracture Repair Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Collapse of the vertebrae due to trauma, osteoporosis or other causes of weakening of the vertebrae is known as vertebral compression fracture (VCF). VCF is more common in people with low bone mass or suffering from osteoporosis. Some of the common symptoms of VCF include, back pain lasting for more than 2-3 weeks, limited spinal mobility, vertebral height loss over time and kyphosis, disability and deformity over a period of time. Vertebral compression fracture is treated primarily with pharmacological therapy and prolonged bed rest. Surgically, VCFs are treated with minimally invasive VCF repair techniques in cases where medicinal therapies fail to cure VCF. Minimally invasive vertebral compression repair techniques include two procedures, namely, vertebroplasty and balloon kyphoplasty. Both vertebroplasty and kyphoplasty involve injection of medical grade cement in the fractured vertebra. Kyphoplasty is a newer and evolved form of vertebroplasty, where a balloon is inserted in the vertebral body and inflated to restore the original height of the collapsed vertebra and is thereafter followed by cement injection. Vertebroplasty successfully relives pain and enhances mobility of the patient; while on the other hand, balloon kyphoplasty not only relives the pain but also restores vertebral height and assists in curing kyphosis. Kyphoplasty has also demonstrated a lesser complication rate post procedure when compared with vertebroplasty. This has over the time resulted in higher adoption of kyphoplasty procedures worldwide, particularly in North America. One of the major factors that is contributing to rapid increase in the adoption of kyphoplasty procedure in North America is the recommendation of the use of this technique by the American Academy of Orthopedic Surgeons (AAOS) for VCF repair when conventional drug administration fails to deliver the desired results. Considering the advantages of kyphoplasty over vertebroplasty, the kyphoplasty market share will rapidly increase in the near future. The global market for balloon kyphoplasty was worth USD 555.4 million in 2011. Key Topics Covered - Introduction - Executive Summary - Market Overview - Global Minimally Invasive Vertebral Compression Fracture Repair Market, by Technology - Global Minimally Invasive Vertebral Compression Fracture Repair Market, by Geography - Recommendations - Company Profiles Companies Mentioned - Alphatec Spine - CareFusion - Cook Medical - DFine - DePuy Synthes - Globus Medical - Medtronic - Parallax Medical - Stryker Corporation - Zimmer Holdings Incorporated For more information visit http://www.researchandmarkets.com/research/8m57sq/minimally About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
MedMined® Surveillance Advisor Named KLAS Category Leader For Infection Control And Monitoring
PR Newswire - Wed Feb 19, 7:30AM CST
CareFusion (NYSE:CFN), a leading global medical technology company, today announced its MedMined® Surveillance Advisor was named the Category Leader for Infection Control and Monitoring by KLAS, an organization that independently monitors health care information technology performance through the active participation of thousands of health care organizations.
Children's Hospitals and Clinics of Minnesota Receives 2014 Intelligent Hospital Award
PR Newswire - Tue Feb 18, 7:30AM CST
The RFID in Healthcare Consortium (RHCC) and IntelligentHospital.org today announced that Children's Hospitals and Clinics of Minnesota has received a 2014 Intelligent Hospital Award for "Improving the Patient Experience: Care and Safety" for its infusion pump interoperability solution collaboration with CareFusion (NYSE: CFN) and Cerner (NASDAQ: CERN).
ICU Medical, Inc. Names Vivek Jain as New Chief Executive Officer and Chairman
GlobeNewswire - Wed Feb 12, 3:07PM CST
ICU Medical, Inc., (Nasdaq:ICUI), a leader in innovative medical devices used in infusion therapy, oncology and critical care applications, announced today the appointment of Vivek Jain as chairman and chief executive officer effective February 13, 2014, concluding a transition process that began when Dr. George Lopez announced his decision to retire as CEO in the fall of 2013. Steve Riggs, the Company's current acting Chief Executive Officer, will immediately resume his previous responsibilities as vice president of Operations.
BlueCross BlueShield of Tennessee Selects RxAnte To Provide Medication Quality Analytics
PR Newswire - Wed Feb 12, 7:00AM CST
Today, RxAnte, Inc., a health care analytics and technology company specializing in improving medication use, announced that BlueCross BlueShield of Tennessee, Inc. joins a growing list of health care organizations working with RxAnte to improve patient health. Under the terms of the agreement, RxAnte will provide two of its software solutions and analytic tools to BlueCross BlueShield of Tennessee to guide medication improvement programs for their Medicare Advantage population.
Insider Trading Alert - CFN, SCHW, BSX, HES And FCX Traded By Insiders
at The Street - Mon Feb 10, 9:15AM CST
Stocks with insider trader activity include CFN, SCHW, BSX, HES and FCX
Insider Trading Alert - CFN, MD, PNC, ITMN And PLCM Traded By Insiders
at The Street - Thu Feb 06, 11:00AM CST
Stocks with insider trader activity include CFN, MD, PNC, ITMN and PLCM
Watch for CareFusion to Potentially Rebound After Falling 2.91% Yesterday
Comtex SmarTrend(R) - Tue Feb 04, 4:33PM CST
CareFusion (NYSE:CFN) traded in a range yesterday that spanned from a low of $38.00 to a high of $39.47. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $39.48 on volume of 6.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
After Yesterday's Decline of 2.91%, CareFusion Offers Investors Better Value
Comtex SmarTrend(R) - Tue Feb 04, 4:32PM CST
CareFusion (NYSE:CFN) traded in a range yesterday that spanned from a low of $38.00 to a high of $39.47. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $39.48 on volume of 6.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CareFusion: Flat Earnings, Maintained View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 04, 1:58PM CST
Revenues in the quarter rose 1.4% (both in reported and constant currency) to $922 million, topping the Zacks Consensus Estimate of $912 million
CareFusion (CFN) Crosses Pivot Point Support at $39.21
Comtex SmarTrend(R) - Tue Feb 04, 9:07AM CST
Shares of CareFusion (NYSE:CFN) have bearishly opened below the pivot of $40.06 today and have reached the first support level of $39.21. Analysts will be watching for a cross of the next downside pivot targets of $38.63 and $37.19.
CareFusion Reports First Half Fiscal 2014 Results
PR Newswire - Mon Feb 03, 3:02PM CST
CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its second quarter of fiscal 2014, ended Dec. 31, 2013.
CareFusion Up on Terumo Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 31, 4:45PM CST
CareFusion announced an eight-year agreement with Terumo
Natus Medical Beats on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 30, 2:20PM CST
Natus Medical reported fourth-quarter 2013 adjusted earnings per share (EPS) of 37 cents, surpassing the Zacks Consensus Estimate of 32 cents. It also provided its revenue and EPS outlook for full year 2014.
Concise Analysis on the Internatiuonal Pharmacy Automation Market - Forecasts to 2016
M2 - Thu Jan 30, 5:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/hp6krz/global_pharmacy) has announced the addition of the "Concise Analysis on the Internatiuonal Pharmacy Automation Market - Forecasts to 2016" report to their offering. Increasing customer support services is one of the emerging trends in the Global Pharmacy Automation market. The vendors in the Global Pharmacy Automation market are providing all-inclusive customer support packages with the purchase or rental of pharmacy automation systems. Staff technicians are available toll-free 24 hours a day, 365 days a year for personalized technical support and operational guidance. Some of the vendors provide automated updates of the software and drug database which are included in the support package. Vendors are offering the end-users with several maintenance and post-purchase services to retain the customer base and to remain competitive in the market. The increase in technological innovations is one of the major drivers in the global pharmacy automation market. The demand for pharmacy automation products has increased significantly due to the technological advancements and sophisticated approaches in healthcare industry. Ongoing innovations are contributing to various healthcare operations on a regular basis. There has been increased emphasis on improving medication distribution by the companies and the pharmacies have become more receptive in accepting the same. The market is also expected to be driven by the introduction of advanced robotic prescription dispensing systems, central-fill systems, electronic-prescribing (e-prescribing), telehealth and automated kiosks during the forecast period. Further, the report discusses that intense competition among vendors is one of the major challenges in the Global Pharmacy Automation market. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Coverage 4. Market Landscape 5. Geographical Segmentation 6. Vendor Landscape 7. Buying Criteria 8. Market Growth Drivers 9. Drivers and their Impact 10. Market Challenges 11. Impact of Drivers and Challenges 12. Market Trends 13. Key Vendor Analysis 14. Other Reports in this Series Companies Mentioned: - CareFusion - Kirby Lester - McKesson - Omnicell - Parata Systems - ScriptPro - Swisslog Holdings For more information visit http://www.researchandmarkets.com/research/hp...l_pharmacy
